Detailed View
WST - West Pharmaceutical Services, I
Latest filing: 2026-09-30 | Reporting: gaap
Market Cap
29,258,721,280
Adj EBIT (TTM)
808,700,000
Enterprise Value
29,006,421,280
Last Price
415.75
Earnings Yield
2.79%
Return on Capital
24.49%
Capital
3,301,500,000
1Y Price Chart
Last Price: $415.75
1Y Change: 46.65%
As of 2026-10-29 | 1Y Change: 46.65%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-09-30 | 10-Q | 2026 | 874,500,000 | 267,400,000 |
| 2026-06-30 | 10-Q | 2026 | 872,300,000 | 179,100,000 |
| 2026-03-31 | 10-Q | 2026 | 844,900,000 | 177,100,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 805,000,000 | 156,600,000 |
| 2025-09-30 | 10-Q | 2025 | 804,600,000 | 167,600,000 |
| 2025-06-30 | 10-Q | 2025 | 766,500,000 | 153,700,000 |
| 2025-03-31 | 10-Q | 2025 | 698,000,000 | 107,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 748,800,000 | 159,600,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.